Influence of FOXP3 single-nucleotide polymorphism after allogeneic hematopoietic stem cell transplantation

The impact of FOXP3 single-nucleotide polymorphisms (SNP) on clinical outcomes after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains poorly understood. We investigated the relationship between a FOXP3 SNP (rs3761548) and clinical outcomes in 91 patients with hematological malignancies after allo-HSCT. Multivariate analysis showed that risk of severe chronic graft-versus-host disease (cGVHD) was significantly higher in patients with the FOXP3 -3279C/A or FOXP3 -3279A/A genotype than those with the FOXP3 -3279C/C genotype [hazard ratio (HR), 2.69; 95% confidence interval (CI) 1.14–6.31; p = 0.023]. Therefore, FOXP3 at SNP rs3761548 can be a useful marker for predicting the occurrence of severe cGVHD.